PRODUCTS SOLD BY ASCEND PEPTIDES ARE INTENDED FOR RESEARCH USE ONLY.
PRODUCTS SOLD BY ASCEND PEPTIDES ARE INTENDED FOR RESEARCH USE ONLY.
BPC-157 10mg research peptide is a synthetic pentadecapeptide of gastric origin studied for nitric oxide pathway activity, VEGF signalling, and gut biology research in UK laboratories. ≥98% HPLC-verified. Janoshik tested. Same-day UK dispatch before 4pm. For in-vitro research use only.
Safety Information: Not intended for human or veterinary use. Use appropriate laboratory safety procedures when handling.
BPC-157 10mg should only be used in laboratory settings by qualified personnel.
Ensure all experimental procedures comply with local and institutional regulations.
This peptide is supplied for research and scientific study purposes only.
BPC-157 10 mg:
Click Here To View
Research use only • UK dispatch • Orders before 4pm ship same day • Secure checkout
BPC-157 10mg Research Peptide UK
BPC-157 10mg is a synthetic pentadecapeptide consisting of 15 amino acids, derived from a partial peptide sequence associated with gastric protein research. With a molecular formula of C62H98N16O22 and a molecular weight of approximately 1,419.53 g/mol, the bpc 157 10mg research peptide has accumulated a substantial body of published preclinical literature across multiple research disciplines.
The primary mechanism of BPC-157 in laboratory research models involves the nitric oxide (NO) signalling pathway, specifically modulating nitric oxide synthase (NOS) activity in vascular and tissue cell models. Additional documented interactions include VEGF (vascular endothelial growth factor) signalling and EGF receptor pathway activity. The gastric origin of BPC-157 makes it particularly relevant to gastrointestinal and gut mucosal biology research, an area where the mechanistically distinct TB-500 10mg has no published presence.
Published preclinical literature covering the bpc 157 10mg research compound includes tendon cell models, bone cell culture studies, wound closure assays, nitric oxide pathway investigations, angiogenesis research, and inflammatory cytokine studies. The 10mg format supports full dose-response concentration gradients, multi-arm experimental designs, and extended single-batch protocols.
BPC-157 10mg and TB-500 10mg are both compounds that can function as independent variables within the same experimental system. BPC-157 acts through the NO and VEGF pathways; TB-500 acts through actin-binding and cytoskeletal dynamics. These distinct mechanisms mean both compounds can function as independent variables within the same experimental system. Researchers comparing both compounds in parallel can find detailed mechanistic analysis in the BPC-157 10mg research guide on the Ascend Peptides UK blog.
In skin and cellular biology research, BPC-157 10mg is also frequently studied alongside GHK-CU 50mg. These two skin research peptides operate through distinct mechanisms — BPC-157 via NO pathway activity, GHK-CU via copper chaperone and ECM interactions — making them complementary in multi-compound cellular biology protocols.
Every batch of BPC-157 10mg from Ascend Peptides UK is independently tested by Janoshik. HPLC purity is confirmed at greater than or equal to 98%, with LC-MS molecular identity confirmed at C62H98N16O22 and approximately 1,419.53 g/mol. The full batch-specific Certificate of Analysis is available for independent verification.
Reconstitute with BP-grade bacteriostatic water for research. Gently swirl to dissolve. Aliquot immediately. Store at minus 20°C.
WADA Status: Listed on the WADA Prohibited List, prohibited at all times.
DISCLAIMER: For in-vitro laboratory research only. Not for human consumption or clinical use. Not an MHRA-licensed medicine.
A curated entry point for buyers comparing quality, documentation, and availability.
UK same-day dispatch – PCI-
compliant payments –
Laboratory research only
© 2026 by Ascend Peptides Uk.
